| Literature DB >> 30624847 |
Lukas J Jongkind1, Johannes A A W Elemans2, Joost N H Reek1.
Abstract
Supramolecular approaches in transition-metal catalysis, including catalyst encapsulation, have attracted considerable attention. Compared to enzymes, supramolecular catalysts in general are less complex. Enzyme activity is often controlled by the use of smaller cofactor molecules, which is important in order to control reactivity in complex mixtures of molecules. Interested in increasing complexity and allowing control over supramolecular catalyst formation in response to external stimuli, we designed a catalytic system that only forms an efficient supramolecular complex when a small cofactor molecule is added to the solution. This in turn affects both the activity and selectivity when applied in a hydroformylation reaction. This contribution shows that catalyst encapsulation can be controlled by the addition of a cofactor, which affects crucial catalyst properties.Entities:
Keywords: bioinspired catalysis; catalyst encapsulation; complex chemical systems; hydroformylation; supramolecular chemistry
Year: 2019 PMID: 30624847 PMCID: PMC6563692 DOI: 10.1002/anie.201812610
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Figure 1Schematic of cofactor‐controlled encapsulation. The individual components present in solution form a bisphosphine rhodium complex, and the introduction of the cofactor activates the porphyrin for coordination, thereby initiating capsule formation around the catalyst.
Figure 2Ligand template 1, which was previously used to generate encapsulated rhodium catalysts through pyridyl coordination to zinc(II) porphyrins. Binding of dimethylviologen as a cofactor inside clip 2 activates the zinc porphyrin for binding, leading to a more than 100‐fold enhancement in the association constant with the pyridine derivatives through so‐called allosteric magnification.
Figure 3Cofactor controlled encapsulation of a rhodium complex for hydroformylation. When the viologen cofactor is not present, the pyridyl group of template ligand 1 has weak interactions with zinc porphyrin cage 2, and bisphosphine rhodium complexes are formed in solution. Addition of the cofactor causes a much stronger interaction of the pyridyl groups of 1 with the zinc porphyrin, leading to the formation of an encapsulated monophosphine rhodium complex. An xTB‐optimized structure is shown (for details, see the Supporting Information),46 with the viologen shown in red, clips shown in blue, and the HRh(1)(CO)3 complex shown in CPK colouring.
Hydroformylation of 1‐octene with various combinations of ligands, capsule constituents, and cofactor.[a]
| Ligand[b] | Cofactor | Yield [%][c] | l/b ratio[c] |
|---|---|---|---|
| Phosphine | – | 17 | 2.4 |
| Phosphine | viologen | >99 | 0.71 |
| Phosphine | – | 11 | 2.9 |
| Phosphine | viologen | 13 | 2.9 |
| Phosphine | – | >99 | 0.60 |
| Phosphine | viologen | 44 | 0.67 |
[a] Conditions: [Rh(acac)(CO)2]=1.0 mm, T=25 °C, t=24 h, p=20 bar (CO/H2=1:1), solvent: dichloromethane/acetonitrile=4:1. [b] phosphine/rhodium=2.5:1, porphyrin/phosphine=3:1, cofactor/porphyrin=1.1:1; substrate/Rh=800:1. [c] Yield of aldehyde products, determined by GC with decane as an internal standard, selectivity confirmed by NMR (Figures S20,21).
Figure 4Yield of the hydroformylation of 1‐octene (combined products) in the presence and absence of the cofactor in the initial phase of the reaction (up to 2.5 % conversion). TOFs in (mol aldehyde) (mol Rh)−1 h−1 were determined from the slopes of the curves.